Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00821288 · ClinicalTrials.gov registry record · NA
Post-treatment Care of Breast Cancer Survivors
A NA study of Breast Neoplasm, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT00821288: Completed NA study of Breast Neoplasm, sponsored by Columbia University.
NCT00821288 is a NA study of Breast Neoplasm that has completed, run by Columbia University. The registered enrollment target is 140 participants, below the 157-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00821288, a NA study of Breast Neoplasm, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this proposal is to improve the post-treatment care of breast cancer survivors and to understand the barriers to optimal post-treatment care in Latina and Non-Hispanic women.
Primary Outcome
This is designed to measure change in positive health related behavior.
Conditions Studied
Interventions
- BEHAVIORAL Survivorship Intervention
- BEHAVIORAL Facing Forward
Study Locations (1)
New York
- Columbia Unviersity Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2007-07 |
| Est. Completion | 2013-05 |
| Phase | NA |
What the finished NCT00821288 record still lists
NCT00821288 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 157-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (11% lower).
The record links to 1 condition, with Breast Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Survivorship Intervention is the first listed.
NCT00821288 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00821288 about?
NCT00821288 is a clinical study titled "Post-treatment Care of Breast Cancer Survivors". The overall goal of this proposal is to improve the post-treatment care of breast cancer survivors and to understand the barriers to optimal post-treatment care in Latina and Non-Hispanic women.
What is the current status of trial NCT00821288?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2007-07. Estimated completion is 2013-05.
What conditions does trial NCT00821288 study?
This clinical trial studies the following conditions: Breast Neoplasm.
What interventions are being tested in trial NCT00821288?
The interventions under investigation include: Survivorship Intervention (BEHAVIORAL), Facing Forward (BEHAVIORAL).
Who is sponsoring clinical trial NCT00821288?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00821288 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00821288's enrollment target sits among peer trials
140 10th of 26 higher than 17 of 26 other Breast Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
RECRUITING · NA
-
Cryoablation vs Lumpectomy in T1 Breast Cancers
RECRUITING · NA
-
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
RECRUITING · NA
-
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
ACTIVE NOT RECRUITING · NA
-
Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting
COMPLETED · NA
-
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia